Giuseppe Lopalco
@giuseppelopalc2
Associate Professor in #Rheumatology at @unibait | Member of @official_ASAS and AIDA Network | Editor for @ojrarediseases and @Frontimmunol
ID: 1436680419613810693
https://pubmed.ncbi.nlm.nih.gov/?term=Lopalco+g&sort=date 11-09-2021 13:18:12
240 Tweet
477 Takipçi
449 Takip Edilen
📢 New study on Secukinumab in PsA! 🏥 from GISEA 🔹 63.2% drug survival at 24 months 🔹 Improved disease activity (DAPSA, PASI, ASDAS-CRP) 📉 🔹 Higher persistence in mixed PsA (peripheral+axial) 🔹 Well-tolerated, no serious AEs! 💊✅ Sage Journals 🔗 doi.org/10.1177/175972…